Cited by 335Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Differences in neuropathologic characteristics across the Lewy body dementia spectrum

Open access

Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., Aarsland, D.·2006·Neurology

DOI 10.1212/01.wnl.0000249130.63615.cc

Open this paper in CoChat — free account

Abstract

BACKGROUND: The objective of this comparative neuropathologic study was to determine the extent to which dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) are distinct entities or part of a continuum with respect to the duration of parkinsonism. METHODS: We evaluated the relationship between cortical alpha-synuclein pathology, plaques (Consortium to Establish a Registry for Alzheimer's Disease [CERAD]), tangles (Braak staging), and cholinergic deficits (choline acetyltransferase in temporal cortex) in 57 prospectively assessed patients (29 DLB, 28 PDD), confirmed at autopsy. The PDD group was divided according to the median duration of parkinsonism prior to dementia. RESULTS: There was an association between longer duration of parkinsonism prior to dementia and less severe cortical alpha-synuclein pathology (chi(2) 10.4, df 2, p = 0.006) and lower CERAD plaque scores (chi(2) 26.6, df 9, p = 0.002), but not Braak staging. These findings were confirmed in a further correlation analysis, which also identified an unexpected correlation between more pronounced cortical cholinergic deficits and longer duration of parkinsonism prior to dementia (R = -0.37, p = 0.04). CONCLUSION: While there is a clear relationship between the duration of Parkinson disease prior to the onset of dementia and key neuropathologic and neurochemical characteristics, there is a gradation of these differences across the dementia with Lewy bodies/Parkinson disease dementia spectrum and the findings do not support an arbitrary cut-off between the two disorders.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000249130.63615.cc

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citation
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding, A., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609
Senile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., FAIRBAIRN, A. F., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 575
Self-citation
Parkinson Disease Neuropathology
Apaydın, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.102 · Cited by 397

Show all 28 references

Research works printed but not linked: 3

Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229–237.
Perry RH Jaros E Hall RA et al. Proposal for modification of consensus guidelines for the neuropathological diagnosis of dementia with Lewy bodies (DLB) when using alfa-synuclein IHC. Third International Workshop on Dementia with Lewy Bodies and Parkinson's Disease. Dementia. Vol. 158. Newcastle upon Tyne UK 2003;158.
Lippa SM, Lippa CF, Mori H. Alpha-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am J Alzheimers Dis Other Dement 2005;20:315–318.

Sorted by citations

Items 201–300 of 335

Dementia in Parkinson's Disease
Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17
Tracer kinetic model detecting heterogeneous blood–brain barrier permeability to water and contrast agent in Alzheimer's disease and dementia with Lewy bodies
Xu, Z., Ji, Y., Chen, W., Gan, J., Chen, Z., Li, R., Lin, X., Dou, J., Wang, Y., Liu, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14529 · Cited by 14
Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia
Gupta, V., Verma, R., Ranjan, R., Belho, E. S., Seniaray, N., Dinand, V., Malik, D., & Mahajan, H. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001102 · Cited by 14
Neuropathology of dementia with Lewy bodies
Lowe, J. S. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01231-6 · Cited by 14
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias
Shellikeri, S., Cho, S., Cousins, K. A. Q., Liberman, M., Howard, E., Balganorth, Y., Weintraub, D., Spindler, M., Deik, A., Lee, E. B., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.07.023 · Cited by 12
Clinical impact of 11 C ‐Pittsburgh compound‐ B positron emission tomography carried out in addition to magnetic resonance imaging and single‐photon emission computed tomography on the diagnosis of A lzheimer's disease in patients with dementia and mild cognitive impairment
Omachi, Y., Ito, K., Arima, K., Matsuda, H., Nakata, Y., Sakata, M., Sato, N., Nakagome, K., & Motohashi, N. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12326 · Cited by 13
The pattern of cortical atrophy in Parkinson’s disease with mild cognitive impairment according to the timing of cognitive dysfunction
Lee, J. E., Cho, K. H., Kim, M., Sohn, Y. H., & Lee, P. H. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6203-x · Cited by 13
Molecular Imaging of Dementia With Lewy Bodies
Cousins, O., Yousaf, T., Wilson, H., Pagano, G., & Politis, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.10.007 · Cited by 12
Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
Sheng, Z.-H., Ma, L., Liu, J.-Y., Ou, Y., Zhao, B. T., Ma, Y., & Tan, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1061096 · Cited by 12
Amyloid PET in neurodegenerative diseases with dementia
Camacho, V., Gómez‐Grande, A., Sopena, P., Solís, D. G., Río, M. G., Lorenzo‐Bosquet, C., Rubí, S., & Arbizu, J. (2018) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2018.04.003 · Cited by 12
Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
Lyoo, C. H., Cho, H., Choi, J. Y., Ryu, Y. H., & Lee, M. S. (2018) · Journal of Movement Disorders · doi:10.14802/jmd.17071 · Cited by 12
Elucidating distinct molecular signatures of Lewy body dementias
Harvey, J., Pishva, E., Chouliaras, L., & Lunnon, K. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106337 · Cited by 11
Classification des démences : aspects nosologiques
Bakchine, S., & Habert, M. (2007) · Médecine Nucléaire · doi:10.1016/j.mednuc.2007.04.005 · Cited by 11
Mild cognitive impairment in Parkinson’s disease
Korczyn, A. D. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1006-0 · Cited by 11
Dopaminergic imaging: clinical utility now and in the future
Walker, Z., & Rodda, J. E. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000883 · Cited by 10
A Preliminary Comparison of the Methylome and Transcriptome from the Prefrontal Cortex Across Alzheimer’s Disease and Lewy Body Dementia
Fisher, D. W., Tulloch, J., Yu, C., & Tsuang, D. W. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr220114 · Cited by 9
A Parkinson-kórhoz társuló demencia és a Lewy-testes demencia patológiai és klinikai összehasonlítása
Bencs, V., Bencze, J., Módis, V. L., Simon, V., Kálmán, J., & Hortobágyi, T. (2020) · Orvosi Hetilap · doi:10.1556/650.2020.31715 · Cited by 9
Co‐ and Multi‐Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review
Matarazzo, M., Borghammer, P., Elsayed, I., Goldman, J. G., Huang, Y., Lohmann, K., Svenningsson, P., Kalia, L. V., Berg, D., & Kordower, J. H. (2026) · Movement Disorders · doi:10.1002/mds.70324 · Cited by 11
Amitriptyline improves cognitive and neuronal function in a rat model that mimics dementia with lewy bodies
Lin, C., Zheng, T.-L., Tsou, S., Chang, H., Tseng, L., Yu, C., Hung, C., & Ho, Y. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114035 · Cited by 8
PET amiloide en enfermedades neurodegenerativas que cursan con demencia
Camacho, V., Gómez‐Grande, A., Sopeña, P., García-Solís, D., Río, M. G., Lorenzo‐Bosquet, C., Rubí, S., & Arbizu, J. (2018) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2018.03.004 · Cited by 9
Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects
Blanc, F., & Bousiges, O. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.008 · Cited by 11
Cognitive dysfunction in animal models of human lewy-body dementia
Haikal, C., Winston, G. M., & Kaplitt, M. G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1369733 · Cited by 7
Parkinsonian Dementias
Possin, K., & Kaufer, D. (2010) · Continuum · doi:10.1212/01.con.0000368212.86835.a8 · Cited by 4
Démences : où sont les corps de Lewy ?
Lebouvier, T., Delrieu, J., Evain, S., Pallardy, A., Sauvaget, A., Letournel, F., Chevrier, R., Lepetit, M., Vercelletto, M., Boutoleau‐Bretonnière, C., et al. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.05.004 · Cited by 7
Relación entre temblor esencial, enfermedad de Parkinson y demencia con cuerpos de Lewy
Bermejo, P. E., Ruíz-Huete, C., & Cuadrado, C. T. (2007) · Revista de Neurología · doi:10.33588/rn.4511.2007460 · Cited by 7
Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort
Bousiges, O., Cretin, B., Muller, C., Botzung, A., Sanna, L., Anthony, P., Philippi, N., Demuynck, C., & Blanc, F. (2023) · GeroScience · doi:10.1007/s11357-023-00883-6 · Cited by 7
Kisspeptin-10 Mitigates α-Synuclein-Mediated Mitochondrial Apoptosis in SH-SY5Y-Derived Neurons via a Kisspeptin Receptor-Independent Manner
Simon, C., Soga, T., & Parhar, I. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076056 · Cited by 6
Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson’s disease with dementia
Ishizawa, K., Fujita, Y., Nagashima, K., Nakamura, T., Shibata, M., Kasahara, H., Makioka, K., Taketomi-Takahashi, A., Hirasawa, H., Higuchi, T., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120713 · Cited by 6
18F ‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies
Tang, G., Lu, J., Li, X., Yao, R., Yang, Y., Jiao, F., Chen, M., Liang, X., Ju, Z., Ge, J., et al. (2024) · Movement Disorders · doi:10.1002/mds.30055 · Cited by 6
Assessment of Amyloid Deposition in Patients With Probable REM Sleep Behavior Disorder as a Prodromal Symptom of Dementia With Lewy Bodies Using PiB-PET
Kobayashi, R., Hayashi, H., Kawakatsu, S., Okamura, N., Yoshioka, M., & Otani, K. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00671 · Cited by 5
Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?
Irwin, D. J. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03060-5 · Cited by 6
Generalized Rhythmic Delta Activity Frontally Predominant Differentiates Dementia with Lewy Bodies From Alzheimer's Disease and Parkinson's Disease Dementia: A Conventional Electroencephalography Visual Analysis
Zinno, L., Negrotti, A., Falzoi, C., Messa, G., Goldoni, M., & Calzetti, S. (2021) · Clinical EEG and Neuroscience · doi:10.1177/1550059421997147 · Cited by 5
Combined 18F‐FDG PET‐CT markers in dementia with Lewy bodies
Mattoli, M. V., Cocciolillo, F., Chiacchiaretta, P., Dotta, F., Trevisi, G., Carrarini, C., Thomas, A., Sensi, S. L., Pizzi, A. D., Nicola, A. D. D., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12515 · Cited by 5
Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis
Trompeta, C., Gasca‐Salas, C., Rodríguez‐Rojas, R., Fernández‐Rodríguez, B., Clarimón, J., García‐Cañamaque, L., Guida, P., Hernández‐Fernández, F., Sánchez‐Juan, P., Olazarán, J., et al. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123510 · Cited by 6
Past appendectomy may be related to early cognitive dysfunction in Parkinson’s disease
Goncalves, A. R., Mendes, A., Vila‐Chã, N., Damásio, J., Fernandes, J., & Cavaco, S. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04507-1 · Cited by 5
Characterizing clinical phenotypes
Lippa, C. F., & Emre, M. (2006) · Neurology · doi:10.1212/01.wnl.0000250234.72903.37 · Cited by 5
The genetics of dementia with Lewy bodies
Tolea, M. I., & Galvin, J. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00028-4 · Cited by 6
Study protocol on Alzheimer’s disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions
Boublay, N., Fédérico, D., Pesce, A., Verny, M., Blanc, F., Paccalin, M., Desmidt, T., Grosmaître, P., Moreaud, O., Relland, S., et al. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0949-2 · Cited by 4
Movement Disorders
Jankovic, J. J., & Shannon, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50113-8 · Cited by 4
Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias
Mohamed, N., Howlett, D. R., Ma, L., Francis, P. T., Aarsland, D., Ballard, C. G., McKeith, I. G., Chen, C., & Lai, M. K. P. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1067-0 · Cited by 4
Self-citation
G protein-coupled receptors in drug discovery for neurological and psychiatric disorders: therapeutic targets, mechanisms, and future prospects
Zhang, M., Rehman, M. U., & Long, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117380 · Cited by 5
Functional Imaging of Cognitive Impairment in Parkinson's Disease
Fitzpatrick, T., Mattis, P., & Eidelberg, D. (2010) · Clinical EEG and Neuroscience · doi:10.1177/155005941004100303 · Cited by 3
Different patterns of β-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism
Chung, S. J., Lee, S., Yoo, H. S., Baik, K., Lee, H. S., Jung, J. H., Choi, Y., Hong, J., Kim, Y. J., Ye, B. S., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.022 · Cited by 3
Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study
Xue, X., Mei, S., Huang, A., Wu, Z., Zeng, J., Song, H., An, J., Zhang, L., Liu, G., Zhou, L., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14080787 · Cited by 3
SPECT/PET Findings in Lewy Body Dementia
Ducksbury, R., Whitfield, T. J., & Walker, Z. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_17 · Cited by 3
The more cortical amyloid‐β, the more postural instability in parkinson's disease: More grist to the mill for a link between walking, falling, and remembering?
Compta, Y., Révész, T., & Lees, A. J. (2013) · Movement Disorders · doi:10.1002/mds.25283 · Cited by 3
Movement Disorders with Dementia in Older Adults
Tröster, A. I., & Browner, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3106-0_22 · Cited by 3
Parkinson Dementia: PET Findings
Bohnen, N. I., & Frey, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_16 · Cited by 3
Tau PET imaging evidence in patients with cognitive impairment: preparing for clinical use
Noirot, C., Mainta, I., Mendes, A., Andryszak, P., Visvaratnam, H., Unschuld, P. G., Frisoni, G. B., & Garibotto, V. (2018) · Clinical and Translational Imaging · doi:10.1007/s40336-018-0297-4 · Cited by 3
Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body
Bousiges, O., & Blanc, F. (2018) · Gériatrie et Psychologie Neuropsychiatrie du Viellissement · doi:10.1684/pnv.2018.0731 · Cited by 3
When does cerebral β‐amyloid deposition begin in Lewy body dementia?
Fujishiro, H., & Kosaka, K. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12372 · Cited by 4
SPECT/PET Findings in Dementia with Lewy Bodies
Zabihi, S., Whitfield, T. J., & Walker, Z. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_17 · Cited by 3
Parkinsonian Dementias: PET Findings
Kanel, P., Müller, M. L. T. M., & Bohnen, N. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_16 · Cited by 4
Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00009-3 · Cited by 2
Cognitive impairment in advanced Parkinson's disease
Murakami, T., & Hanajima, R. (2022) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12599 · Cited by 2
Dementia: A journey from cause to cure
Kumari, S., Bagri, K., & Deshmukh, R. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824331-2.00011-x · Cited by 2
Comparison of the ability of different quantitative indices in 123I-FP-CIT single-photon emission computed tomography to differentiate dopaminergic neurodegenerative disease
Sato, T., Sawai, S., & Shimada, N. (2024) · Japanese Journal of Radiology · doi:10.1007/s11604-024-01648-7 · Cited by 2
Cerebral microbleeds: prevalence and relationship to clinical features in cognitive impairment with lewy body disease
Ren, Z., Gan, J., Chen, Z., Shi, Z., Liu, S., Lu, H., Zhang, G., & Ji, Y. (2025) · BMC Neurology · doi:10.1186/s12883-025-04181-w · Cited by 2
Dementia in Parkinson’s Disease and Atypical Parkinsonism
Stamelou, M., & Bhatia, K. P. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6365-7_11 · Cited by 2
Reappraisal of the Cerebral Blood Flow Measured Using 123I-I-iodoamphetamine Single-photon Emission Computed Tomography in Normal Subjects and Patients with Alzheimer’s Disease and Dementia with Lewy Bodies
Seto, M., Fukushima, N., Yuasa, T., Nakao, Y. K., Ichinose, K., Tomita, I., Satoh, H., Satoh, K., Ochi, M., & Tsujihata, M. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.11343/amn.64.91 · Cited by 2
Analysis of the influence of the anisotropy induced by cold rolling on duplex and super-austenitic stainless steels
Finelli, A., & Labanti, M. (2010) · Frattura ed Integrità Strutturale · doi:10.3221/igf-esis.13.03 · Cited by 2
Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00009-3 · Cited by 2
Intriguing Mixed Pathologic Features in a Case of Dementia With Lewy Bodies
Balin, B. J., Hammond, C. J., & Galluzzi, K. E. (2019) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2019.106 · Cited by 2
Neuropathology of Movement Disorders
Jellinger, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00076-9 · Cited by 2
Parkinson’s Disease Dementia
Bılgıç, B., Hanagasi, H. A., & Emre, M. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_3 · Cited by 2
Nonmotor Problems in Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50011-5 · Cited by 2
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Gaskell, H., Burns, A. S., Fox, C., Maidment, I. D., Pettit, T. A., Wild, R., McShane, R. H., & Boustani, M. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006504 · Cited by 2
Clinical aspects of Parkinson dementia
Aarsland, D., & Janvin, C. C. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01228-6 · Cited by 1
Self-citation
Pathogenesis of neurodegenerative diseases via templated recruitment
Guo, J. (2013) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
The Value of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Dementia
Bastard, N. L., & Engelborghs, S. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.11 · Cited by 1
Amyloid imaging in dementia
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
Imaging, Cognition, and Parkinson's Disease—An Overview
Mattis, P., & Eidelberg, D. (2010) · touchREVIEWS in Neurology · doi:10.17925/usn.2010.05.02.26
Early cognitive impairment
Tröster, A. I., & Aarsland, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.016 · Cited by 2
Self-citation
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria
Sestini, S., Alongi, P., Berti, V., Calcagni, M. L., Cecchin, D., Chiaravalloti, A., Chincarini, A., Cistaro, A., Guerra, U. P., Pappatà, S., et al. (2019) · Clinical and Translational Imaging · doi:10.1007/s40336-019-00321-8 · Cited by 1
Parkinson’s disease and the spectrum of Lewy body disease
Barone, P., Pellecchia, M. T., & Amboni, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920936.003 · Cited by 1
Neuropathological features of cognitive decline in Lewy body dementia
Sengoku, R. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12444 · Cited by 1
Biomarqueurs du liquide cérébrospinal dans la maladie à corps de Lewy
Bousiges, O. (2021) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(21)00192-1 · Cited by 2
Movement Disorders with Dementia in Older Adults
Tröster, A. I., & Abbott, A. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_34 · Cited by 1
Criteria for the diagnosis of dementia
Ballard, C. G., & Bannister, C. (2010) · CRC Press eBooks · doi:10.1201/b13196-6 · Cited by 1
Self-citation
Neurodegeneration
Kwei, K., & Przedborski, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_21 · Cited by 1
CFS Biomarkers in Parkinson’s Disease
Parnetti, L., Castrioto, A., De, C., Chiasserini, D., Tambasco, N., Rossi, A., Balducci, C., Beccari, T., & Calabresi, P. (2011) · InTech eBooks · doi:10.5772/16666 · Cited by 1
Cognitive Impairment in Parkinson's Disease
Ikeda, M. (2019) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.56.199 · Cited by 1
Neurodegenerative Chemosensory Disorders
(2018) · Cambridge University Press eBooks · doi:10.1017/9781139192446.008 · Cited by 1
Nonmotor problems in Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00008-1 · Cited by 1
Disfunción olfatoria y deterioro cognitivo en pacientes con enfermedad de Parkinson
Martínez-Ramírez, D., Llorens‐Arenas, R., Rodríguez‐Violante, M., Cervantes‐Arriaga, A., Morales‐Briceño, H., Velázquez‐Osuna, S., & Calderón‐Fajardo, H. (2014) · Archivos de Neurociencias · doi:10.31157/an.v19i4.58 · Cited by 1
Dementias
Ellison, D., Love, S., Chimelli, L. M. C., Harding, B. N., Lowe, J. S., Vinters, H. V., Brandner, S., & Yong, W. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3515-0.00031-3 · Cited by 1
Parkinson’s disease dementia
Bılgıç, B., Hanagasi, H. A., & Emre, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.017 · Cited by 2
General aspects
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.002 · Cited by 1
Self-citation
Optimization of Cell Culture Procedures for Growing Neural Networks on Microelectrode Arrays
Maria, C. L. S. (2007) · doi:10.12794/metadc5126 · Cited by 1
Neurodegenerative diseases that affect olfaction
Hawkes, C. H., & Doty, R. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575754.006
Verbal Fluency in Parkinson`s disease: neuroanatomical correlates and functional networks modulated by noninvasive brain stimulation
Pereira, J. B. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Is There a Place for Clinical Neurophysiology Assessments in Synucleinopathies?
ONOFRJ, M. C., Bonanni, L., Thomas, A., Ricciardi, L., Ciccocioppo, F., Onofrj, D. M. V., & Anzellotti, F. (2011) · InTech eBooks · doi:10.5772/23894
Quantitative Neuroimaging : : Applications to Normal Aging and Neurodegenerative Disease
Murphy, E. (2014) · eScholarship (California Digital Library)
Brain MRI changes in Parkinson’s disease A cross sectional study
Beyer, M. K. (2007) · NORA - Norwegian Open Research Archives
Cognitive Impairment and the Dementias
Duara, R., Rodriguez, M. J., Loewenstein, D., Farlow, M. R., Ballard, C. G., Chui, H. C., Segal‐Gidan, F., Perry, D. C., Rosen, H. J., Henry, M. L., et al. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch9 · Cited by 1
Self-citation
Neuropathology of Dementia in Parkinson's Disease
Dickson, D. W., & Orr, C. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch14
α-Synuclein pathology in very elderly Finns : A population-based clinico-neuropathologic and molecular genetic study of Dementia with Lewy bodies
Oinas, M. (2009) · Työväentutkimus Vuosikirja
Role of Imaging Techniques in Discerning Neurobehavioral Changes in Ischemic, Neurodegenerative and Demyelinating Disorders
Dalaker, T. O., Beyer, M. K., Stosic, M., & Zivadinov, R. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9831-4_2
Chapitre 17. Prise en charge des troubles cognitifs chez le patient avec maladie de Parkinson et démence
Salmon, É. (2009) · Cairn.info
Specific neuropsychiatric disorders
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.011
Self-citation

Authors: Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D.
Affiliations: King's College London (GB)
From the Wolfson Centre for Age-Related Diseases (C.B.), Wolfson Building, Guy's Campus, King's College London, UK; Institute of Ageing and Health (I.Z., R.P., J.O., I.M., E.P.), Newcastle General Hospital, Newcastle upon Tyne, UK; and Norwegian Center for Movement Disorders (J.P.L., D.A.), Stavanger University Hospital, Stavanger, Norway.
ORCID: Ballard, C.
Perry, R.
O'Brien, J.
McKeith, I.
Aarsland, D.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-12-12
Volume: 67
Issue: 11
Pages: 1931-1934
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/01.wnl.0000249130.63615.cc
OpenAlex: W2107172544
Cited by: 335
References: 28
Citations by year: 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 16 · 2019: 23 · 2018: 23 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 21 · 2013: 25 · 2012: 28
FWCI: 12.73
Type: journal article
Language: en
Open access: green
doi.org
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: dementia with Lewy bodies, Parkinson's disease dementia, alpha-synuclein pathology, Braak staging, cholinergic deficit, choline acetyltransferase, differential diagnosis, neuropathology
MeSH terms: Aged, Aged, 80 and over, Choline O-Acetyltransferase, Female, Humans, Male, Parkinson Disease, Prospective Studies, Temporal Lobe, Time Factors, Neurofibrillary Tangles, Lewy Body Disease, alpha-Synuclein, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Differences in neuropathologic characteristics across the Lewy body dementia spectrum

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks